Study on gastritis with Unani medicine
Phase 3
- Conditions
- Health Condition 1: K297- Gastritis, unspecified
- Registration Number
- CTRI/2023/11/060219
- Lead Sponsor
- Dr Tarannum Khan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having following symptoms
Heartburn
Indigestion
Epigastric pain
Nausea
Vomiting
Loss of appetite
Exclusion Criteria
Uncontrolled diabetes mellitus and hypertension
Pregnancy and lactating mother
Patient with active GI haemorrhage, obstruction and perforation
Gastric carcinoma
Patient with any systemic disease such as hepatorenal, cardiac, pulmonary diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It depends on Relief in symptoms such as epigastric pain, indigestion ,heart burn, nausea, loss of appetiteTimepoint: It can be assessed with in the time period of 45 days
- Secondary Outcome Measures
Name Time Method It depends on relief in nature of disease ,preventing recurrent inflammationTimepoint: It will be assessed after 45 days